Bailard’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,606
Closed -$39K 800
2022
Q3
$39K Sell
19,606
-27,991
-59% -$67K ﹤0.01% 652
2022
Q2
$103K Buy
47,597
+10,697
+29% +$36.3K ﹤0.01% 651
2022
Q1
$137K Buy
+36,900
New +$152K ﹤0.01% 685

Other funds holding LIAN

Bailard's LIAN Position: Q4 2022 in Review

Bailard sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 19,606 shares — an estimated $39K sold.

Bailard first reported a position in LIAN in Q1 2022 and held it in 3 quarters. The position peaked at $137K in Q1 2022. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • Bailard reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Bailard sold 19,606 LianBio American Depositary Shares shares in Q4 2022, an estimated $39K.
  • Bailard first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 3 quarters.
  • Bailard's LianBio American Depositary Shares position peaked at $137K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.